Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be ...
Southfield, Mich.-based Corewell Health and Secaucus, N.J.-based Quest Diagnostics have finalized a lab joint venture and hospital lab management agreement. Five things to know: 1. The new joint ...
Quest Diagnostics is expected to unveil its fourth-quarter results soon, and analysts expect a single-digit growth in ...
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Corewell Health and Quest Diagnostics (DGX) announced the completion of the previously announced transaction to establish a laboratory services ...
Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. The company said its test will span ...
Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...
Quest Diagnostics (NYSE:DGX) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year over year), organic revenue growth of 5.2%, while ...
Quest Diagnostics has completed its previously announced acquisition of certain assets of University Hospital’s outpatient lab services business. The deal affects about 50 locations across the health ...
DGX banks on acquisitions, advanced diagnostics and cost discipline, even as debt levels and macro pressures pose risks.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
The company’s powerful regional network of laboratories and its ever-expanding set of diagnostic products are locking in its long term growth potential. Boasting revenues of $7.7 billion in 2019, ...